https://www.labiotech.eu/trends-news/first-toxic-shock-syndrome-vaccine-phase-2-study-completed/
0
0
29 words
0
Comments
The first vaccine to potentially prevent Staphylococcal-induced toxic shock syndrome has successfully completed a phase 2 study.
You are the first to view
Create an account or login to join the discussion